NAPROSYN
ATNAHS PHARMA UK LIMITED
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of NAPROSYN in Canada?
Yes. NAPROSYN 750MG has an active shortage reported to Health Canada (last updated July 27, 2026).
When will NAPROSYN be available again?
No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
NAPROSYN 375MG
SYNTEX INC.
RATIO-NAPROXEN
RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
SYNFLEX TAB 275MG
ALTIMED PHARMA INC.
ANAPROX
SYNTEX INC.
NAPROSYN 250MG
SYNTEX INC.
ANAPROX DS TAB 550MG
SYNTEX INC.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
DIN
02162466
Strength
750MG
Dosage Form
TABLET (EXTENDED-RELEASE)
Route
ORAL
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Other Products from ATNAHS PHARMA UK LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.